Clinically approved iron chelators influence zebrafish mortality, hatching morphology and cardiac function

Autor: Jayachandran N. Kizhakkedathu, Neelima Nair, Jasmine L. Hamilton, Azadeh Hatef, Muhammad Imran ul-haq, Suraj Unniappan
Rok vydání: 2014
Předmět:
lcsh:Medicine
Toxicology
chemistry.chemical_compound
Heart Rate
Medicine and Health Sciences
Cardiac Output
lcsh:Science
Zebrafish
Multidisciplinary
biology
Reproduction
Fishes
Embryo
Heart
Anemia
Hematology
Animal Models
Dose–response relationship
Osteichthyes
Toxicity
embryonic structures
Vertebrates
Deferiprone
medicine.drug
Research Article
animal structures
Iron Chelating Agents
Research and Analysis Methods
Excretion
Andrology
Model Organisms
Toxicity Tests
medicine
Animals
Mortality
Molecular Biology Techniques
Iron Deficiency Anemia
Molecular Biology
Molecular Biology Assays and Analysis Techniques
Dose-Response Relationship
Drug

Hatching
Deferasirox
lcsh:R
Organisms
Biology and Life Sciences
Zebrafish Proteins
biology.organism_classification
Hemoglobinopathies
chemistry
Gene Expression Regulation
lcsh:Q
Zdroj: PLoS ONE
PLoS ONE, Vol 9, Iss 10, p e109880 (2014)
ISSN: 1932-6203
Popis: Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox or L1) are the current standard of care for the treatment of iron overload. Although each chelator is capable of promoting some degree of iron excretion, these chelators are also associated with a wide range of well documented toxicities. However, there is currently very limited data available on their effects in developing embryos. In this study, we took advantage of the rapid development and transparency of the zebrafish embryo, Danio rerio to assess and compare the toxicity of iron chelators. All three iron chelators described above were delivered to zebrafish embryos by direct soaking and their effects on mortality, hatching and developmental morphology were monitored for 96 hpf. To determine whether toxicity was specific to embryos, we examined the effects of chelator exposure via intra peritoneal injection on the cardiac function and gene expression in adult zebrafish. Chelators varied significantly in their effects on embryo mortality, hatching and morphology. While none of the embryos or adults exposed to DFO were negatively affected, ICL -treated embryos and adults differed significantly from controls, and L1 exerted toxic effects in embryos alone. ICL-670 significantly increased the mortality of embryos treated with doses of 0.25 mM or higher and also affected embryo morphology, causing curvature of larvae treated with concentrations above 0.5 mM. ICL-670 exposure (10 µL of 0.1 mM injection) also significantly increased the heart rate and cardiac output of adult zebrafish. While L1 exposure did not cause toxicity in adults, it did cause morphological defects in embryos at 0.5 mM. This study provides first evidence on iron chelator toxicity in early development and will help to guide our approach on better understanding the mechanism of iron chelator toxicity.
Databáze: OpenAIRE